BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Juks C, Lorents A, Arukuusk P, Langel Ü, Pooga M. Cell‐penetrating peptides recruit type A scavenger receptors to the plasma membrane for cellular delivery of nucleic acids. FASEB j 2017;31:975-88. [DOI: 10.1096/fj.201600811r] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Yuan Y, Bar-Joseph Z. GCNG: graph convolutional networks for inferring gene interaction from spatial transcriptomics data. Genome Biol 2020;21:300. [PMID: 33303016 DOI: 10.1186/s13059-020-02214-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
2 Wang J, Chen G, Liu N, Han X, Zhao F, Zhang L, Chen P. Strategies for improving the safety and RNAi efficacy of noncovalent peptide/siRNA nanocomplexes. Advances in Colloid and Interface Science 2022. [DOI: 10.1016/j.cis.2022.102638] [Reference Citation Analysis]
3 Cerrato CP, Langel Ü. An update on cell-penetrating peptides with intracellular organelle targeting. Expert Opin Drug Deliv 2022. [PMID: 35086398 DOI: 10.1080/17425247.2022.2034784] [Reference Citation Analysis]
4 Alothaid H, Aldughaim MSK, El Bakkouri K, AlMashhadi S, Al-Qahtani AA. Similarities between the effect of SARS-CoV-2 and HCV on the cellular level, and the possible role of ion channels in COVID19 progression: a review of potential targets for diagnosis and treatment. Channels (Austin) 2020;14:403-12. [PMID: 33092458 DOI: 10.1080/19336950.2020.1837439] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
5 Kwarteng A, Ahuno ST, Kwakye-Nuako G. The therapeutic landscape of HIV-1 via genome editing. AIDS Res Ther 2017;14:32. [PMID: 28705213 DOI: 10.1186/s12981-017-0157-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
6 Lee HJ, Huang YW, Chiou SH, Aronstam RS. Polyhistidine facilitates direct membrane translocation of cell-penetrating peptides into cells. Sci Rep 2019;9:9398. [PMID: 31253836 DOI: 10.1038/s41598-019-45830-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
7 Langel Ü. Cell-Penetrating Peptides and Transportan. Pharmaceutics 2021;13:987. [PMID: 34210007 DOI: 10.3390/pharmaceutics13070987] [Reference Citation Analysis]
8 Falato L, Gestin M, Langel Ü. PepFect14 Signaling and Transfection. Methods Mol Biol 2022;2383:229-46. [PMID: 34766293 DOI: 10.1007/978-1-0716-1752-6_15] [Reference Citation Analysis]
9 Lorents A, Maloverjan M, Padari K, Pooga M. Internalisation and Biological Activity of Nucleic Acids Delivering Cell-Penetrating Peptide Nanoparticles Is Controlled by the Biomolecular Corona. Pharmaceuticals (Basel) 2021;14:667. [PMID: 34358093 DOI: 10.3390/ph14070667] [Reference Citation Analysis]
10 Dougherty PG, Sahni A, Pei D. Understanding Cell Penetration of Cyclic Peptides. Chem Rev 2019;119:10241-87. [PMID: 31083977 DOI: 10.1021/acs.chemrev.9b00008] [Cited by in Crossref: 123] [Cited by in F6Publishing: 103] [Article Influence: 41.0] [Reference Citation Analysis]
11 McClorey G, Banerjee S. Cell-Penetrating Peptides to Enhance Delivery of Oligonucleotide-Based Therapeutics. Biomedicines 2018;6:E51. [PMID: 29734750 DOI: 10.3390/biomedicines6020051] [Cited by in Crossref: 53] [Cited by in F6Publishing: 40] [Article Influence: 13.3] [Reference Citation Analysis]
12 Bazaz S, Lehto T, Tops R, Gissberg O, Gupta D, Bestas B, Bost J, Wiklander OPB, Sork H, Zaghloul EM, Mamand DR, Hällbrink M, Sillard R, Saher O, Ezzat K, Smith CIE, Andaloussi SE, Lehto T. Novel Orthogonally Hydrocarbon-Modified Cell-Penetrating Peptide Nanoparticles Mediate Efficient Delivery of Splice-Switching Antisense Oligonucleotides In Vitro and In Vivo. Biomedicines 2021;9:1046. [PMID: 34440250 DOI: 10.3390/biomedicines9081046] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]